Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (TA304)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 February 2014
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 January 2012
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 April 2009
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (TA157)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 September 2008